(To see other currencies, click on price)
MORE ABOUT THIS BOOK
Main description:
Remarkable advances have occurred since the Series 3 Fascicle published in 1995 with paradigm shifts in every dimension of our understanding of lung tumors including clinical, radiologic, histopathologic, cytopathologic, immunohistochemical, molecular and therapeutic aspects. The molecular revolution leading to effective targeted therapies and breakthroughs in immunotherapy for lung cancer have led to novel approaches incorporating the concept of personalized medicine for patients who historically had little hope. These advances have strengthened the place of pathologists to play a central role in the multidisciplinary team that is now needed to properly diagnose and manage lung cancer patients.
PRODUCT DETAILS
Publisher: American Registry of Pathology
Publication date: May, 2019
Pages: None
Weight: 2338g
Availability: Available
Subcategories: Oncology, Pathology, Respiratory Medicine